• Imaging Study Suggests Underlying TD Vulnerability, but Experts Raise Methodological Questions

    Imaging Study Suggests Underlying TD Vulnerability, but Experts Raise Methodological Questions
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawCould at least some cases of tardive dyskinesia (TD) reflect an underlying brain vulnerability that antipsychotics expose or accelerate, instead of a straightforward drug effect? That’s the suggestion from a new imaging-based study published in Schizophrenia by researchers in Germany and Switzerland. But two psychiatric pharmacists expressed some skepticism.“I think we know that the pathophysiology of TD i
  • Telehealth and Automation Are Reshaping Compounding

    Telehealth and Automation Are Reshaping Compounding
    By Gina ShawTelehealth has expanded access to compounded medications, but the regulatory framework has struggled to keep pace, speakers said during a virtual care panel at the Informa Connect Compounding Pharmacy Compliance 2026 meeting, in Philadelphia.The COVID-19 pandemic accelerated telehealth adoption “five to 10 years faster than people expected,” said Jeffrey Mesaros, PharmD, JD, a past president of the National Association of Boards of Pharmacy and member of the Florida Board of Phar

Follow @newsl_pharmacy on Twitter!